Flu research ties in COVID-19
We have extended our long-established flu research to include COVID-19(external link). Two large-scale and long-term studies, SHIVERS-II and WellKiwis, will expand to include testing for SARS-CoV-2, the virus that causes COVID-19.
We are undertaking novel research into the testing of wastewater(external link) for the presence of SARS CoV-2.
ESR was the first in New Zealand to sequence the genetic material of SARS CoV-2 from patients(external link).
Sequencing data will provide us with information on the virus and will support the global effort to develop a COVID-19 vaccine.
For a Q & A on genome sequencing - click here
Serological (blood) tests
ESR is evaluating serological (blood) tests that could identify whether people have immunity to COVID-19.
We are collaborating with other organisations to research how we can use novel data sources and machine learning(external link) to predict further outbreaks of COVID-19.
Image: CDC Atlanta